
Apersy is a Life Sciences strategy consultancy specializing in commercial strategy, reimbursement, and market access for disruptive health technologies. They focus on integrating commercial perspectives throughout the development stages of innovative biotech, digital health, AI, and microbiome products. Apersy helps clients de-risk commercialization by providing strategic insights, supporting evidence generation, and shaping products to meet payer and HTA body requirements. Their services include market understanding, opportunity assessment, strategic positioning, evidence generation planning, and value communication. They cater to a range of clients from startups to big pharma, with expertise across European markets.

Apersy is a Life Sciences strategy consultancy specializing in commercial strategy, reimbursement, and market access for disruptive health technologies. They focus on integrating commercial perspectives throughout the development stages of innovative biotech, digital health, AI, and microbiome products. Apersy helps clients de-risk commercialization by providing strategic insights, supporting evidence generation, and shaping products to meet payer and HTA body requirements. Their services include market understanding, opportunity assessment, strategic positioning, evidence generation planning, and value communication. They cater to a range of clients from startups to big pharma, with expertise across European markets.